Please login to the form below

Not currently logged in
Email:
Password:

Aerospan

This page shows the latest Aerospan news and features for those working in and with pharma, biotech and healthcare.

Mylan raises offer for Meda to $9bn

Mylan raises offer for Meda to $9bn

Also due to launch shortly is Aerospan (flunisolide), an inhaler therapy for asthma - incorporating a spacer to improve drug delivery to the lungs - that Meda has said could achieve sales of

Latest news

  • Meda buys US respiratory firm Acton in $200m deal Meda buys US respiratory firm Acton in $200m deal

    Swedish pharma firm gains access to asthma treatment Aerospan. Swedish pharma company Meda has agreed to buy US company Acton in a deal that gives it a ready-to-launch asthma ... product. Meda is paying $125m upfront for Acton, which has been sitting on

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics